| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/19/2002 | CN1354787A Process for purifying human papillomavirus virus-like particles |
| 06/18/2002 | US6406861 Viral diseases and immunogens |
| 06/18/2002 | US6406843 Poultry virus isolates and method |
| 06/18/2002 | US6406842 Providing a sample suspected of containing enterovirus and a mixed cell culture comprising rhabdomyosarcoma cells and human mucoepidermoid cells, inoculating mixed cell culture with sample, observing inoculated culture for enterovirus |
| 06/18/2002 | US6406841 Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides |
| 06/13/2002 | WO2002046477A2 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | WO2002022663A3 Stress resistant retroviruses |
| 06/13/2002 | WO2002008263A3 Modified virus having an altered tropism |
| 06/13/2002 | WO2001096377A3 Vaccine for congenital tremors in pigs |
| 06/13/2002 | WO2000061736A9 Recombinant and mutant marek's disease virus |
| 06/13/2002 | US20020072120 Helper viruses for the preparation of recombinant viral vectors |
| 06/13/2002 | US20020072119 Preventing tumor growth; obtain cells, transform with expression vector, monitor cells for reduction in cell proliferation |
| 06/13/2002 | US20020072094 Generating viral particles; obtain nucleotide sequences, package into vector, insert vector into cells, induce viral particle assembly, recoevr viral particles |
| 06/13/2002 | CA2430379A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | CA2428097A1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/12/2002 | EP1213030A1 Method for producing biologicals in protein-free culture |
| 06/12/2002 | EP1213023A1 Kit comprising reovirus |
| 06/12/2002 | EP1212446A2 Viral replicons and viruses dependent on inducing agents |
| 06/12/2002 | EP1212428A1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 06/12/2002 | EP1212417A2 Interleukin-1-receptor associated kinase-3 (irak3) |
| 06/12/2002 | EP1212084A2 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 06/12/2002 | CN1353769A In vivo selection method for determining inhibitory RNA molecules |
| 06/12/2002 | CN1353763A Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
| 06/12/2002 | CN1353185A Recombinant adenovirus of bone morphogenetic protein and its method for exciting bone generation |
| 06/11/2002 | US6403124 Storage and maintenance of blood products including red blood cells and platelets |
| 06/11/2002 | US6403097 Deletion in the glycoprotein ge-gene |
| 06/06/2002 | WO2002045431A2 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | WO2002044406A2 Projection against mycobacterial infections |
| 06/06/2002 | WO2002044393A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 06/06/2002 | WO2002044374A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/06/2002 | WO2002044348A2 Method for purifying adenoviruses |
| 06/06/2002 | WO2002044347A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it |
| 06/06/2002 | WO2002044334A2 Recombinant rsv virus expression systems and vaccines |
| 06/06/2002 | WO2002044322A2 Bacteriophage composition useful in treating food products to prevent bacterial contamination |
| 06/06/2002 | WO2002044204A2 Cell-free assembly of lentiviral capsids |
| 06/06/2002 | WO2002043754A1 Proteins binding hcv and their medical, diagnostic and purification use |
| 06/06/2002 | WO2002043647A2 Oncolytic virus |
| 06/06/2002 | WO2002028426A8 Split enveloped virus preparation |
| 06/06/2002 | WO2002000906A3 Replication deficient adenoviral tnf vector |
| 06/06/2002 | WO2001079542A3 Hiv detection assay and reagents therefor |
| 06/06/2002 | US20020068368 Viruses to be removed being increased in size by binding to ligands and being held back by filtration. |
| 06/06/2002 | US20020068354 Genetically engineering hematopoietic progenitor cells; obtain cells, transform with vector, monitor cells for expression of vector proteins |
| 06/06/2002 | US20020068267 Process for the sterilization of biological compositions and the product thereby |
| 06/06/2002 | CA2433665A1 Projection against mycobacterial infections |
| 06/06/2002 | CA2430625A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it |
| 06/06/2002 | CA2430495A1 Oncolytic virus |
| 06/06/2002 | CA2430341A1 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | CA2429673A1 Bacteriophage composition useful in treating food products to prevent bacterial contamination |
| 06/06/2002 | CA2425872A1 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/05/2002 | EP1211309A1 Method and apparatus for proliferating hepatitis virus |
| 06/05/2002 | EP1210448A1 Recombinant hsv-1 and live viral vaccines |
| 06/05/2002 | EP1210439A1 Coxsackie virus-derived vector system for gene transfer |
| 06/05/2002 | CN1352693A Insect viral vectors and use thereof |
| 06/04/2002 | US6399385 Conjugating a genetically engineered virus with polyethylene glycol at ambient temperature for improved gene expression |
| 06/04/2002 | US6399354 Fusion protein of icp8 herpes protein which is replication competent in noncomplementing cells and detectable protein; fused to retain open reading frame; for drug screening of viricides and screening of resistant cells |
| 06/04/2002 | US6399353 Biosynthesizing human papillomavirus in epithelial cell containing viral dna but not particles by activating cell differentiation by exposing to protein kinase c inducer; drug screening of viricides |
| 06/04/2002 | US6399308 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses |
| 06/04/2002 | US6399307 Obtaining sample from animal, isolating rna, using ribonuclease resistant standard encapsidated in viral coat protein, and analyzing for presence of indicator sequence |
| 06/04/2002 | US6399294 Probes; primers; immunogens; for diagnosis of human immunodeficiency virus infections |
| 05/30/2002 | WO2002042767A2 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium |
| 05/30/2002 | WO2002042480A2 Modified vaccinia ankara virus variant |
| 05/30/2002 | WO2002042434A1 Cells to be used in producing virus vector, process for producing the same and process for producing virus vector with the use of the cells |
| 05/30/2002 | WO2002002738A3 Host cells containing multiple integrating vectors |
| 05/30/2002 | WO2001068888A3 Production of chimeric capsid vectors |
| 05/30/2002 | US20020064878 Nucleotide sequences for use as tools in genetic engineering |
| 05/30/2002 | US20020064860 Isolating viral particle from mixed sample; obtain sample, expose to chromatographic column, elute, recover viral particles |
| 05/30/2002 | US20020064859 Nuclelotide sequences coding heterologous protein for use in the treatment of cancer, infections, genetic and immunological disorder |
| 05/30/2002 | US20020064853 Nucleotide sequences coding enzymatic polypeptide for use in treatment of cancer, nervous system, cardiovascular and inflammatory disorders, restenosis and arteriosclerosis |
| 05/30/2002 | US20020064534 Herpesvirus preparations and their uses |
| 05/30/2002 | US20020064533 HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 05/30/2002 | US20020064532 Virus mutant of given nucleotide sequence; vaccine can be administered to poultry by mass application routes |
| 05/30/2002 | CA2421151A1 Modified vaccinia ankara virus variant |
| 05/29/2002 | DE10056210A1 Virales Expressionssystem Viral expression system |
| 05/29/2002 | CN1351663A Viral variants |
| 05/29/2002 | CN1351502A Multivaleng dengue virus vaccine |
| 05/29/2002 | CN1351141A Metoxenous armyworm granule virus with synergistic action to insect virus and its preparing process and application |
| 05/28/2002 | US6395875 A polypeptide that binds the d1 domain of the human coxsackie virus; for screening viricidial agents; therapy for respiratory and gastrointestinal infections |
| 05/28/2002 | US6395519 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer |
| 05/28/2002 | US6395512 DNA coding for a peptide of a papilloma virus main capside protein and use thereof |
| 05/28/2002 | US6395495 Methods and kits for detecting antibodies against an HIV variant |
| 05/28/2002 | US6395490 Detecting viral infection in plants; obtain sample, incubate with viral probe, detect hybridization signal, presence of signal indicates that virus infection |
| 05/28/2002 | US6395469 Inactivated respiratory syncytial viral vaccines |
| 05/23/2002 | WO2002040678A1 Small acid-soluble spore protein and uses thereof |
| 05/23/2002 | WO2002040665A2 Complementing cell lines |
| 05/23/2002 | WO2002004595A3 Production of chimeric human papillomavirus |
| 05/23/2002 | WO2001092552A3 Method for the purification of alphavirus replicon particles |
| 05/23/2002 | WO2001083730A3 Recombinant lentiviral vectors pseudotyped in envelopes containing filovirus binding domains |
| 05/23/2002 | WO2001074386A3 Cold-adapted equine influenza viruses |
| 05/23/2002 | WO2001053506A3 Virus strains for the oncolytic treatment of cancer |
| 05/23/2002 | US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 05/23/2002 | US20020061592 Liquid or frozen mixture for use in maintaince of viral particles; for use in gene therapy |
| 05/23/2002 | US20020061553 Partners of the PTB1 domain of FE65, preparation and uses |
| 05/23/2002 | US20020061313 Non-infectious, protease defective HIV particles and nucleic acid molecules encoding therefor |
| 05/23/2002 | US20020061309 Production of peptides in plants as N-terminal viral coat protein fusions |
| 05/22/2002 | EP1207203A2 DNA sequence and papillomavirus vaccine |
| 05/22/2002 | EP1206495A1 Chimeric polypeptides, method for production and uses thereof |
| 05/22/2002 | EP0726947B1 Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders |
| 05/22/2002 | CN1350578A Recombinant influenza viruses for vaccines and gene therapy |
| 05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |